Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency

被引:132
作者
Lu, F
Zhou, J
Wiedmer, A
Madden, K
Yuan, Y
Lieberman, PM
机构
[1] Univ Penn, Wistar Inst, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Microbiol, Sch Dent Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1128/JVI.77.21.11425-11435.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The switch from latent to lytic infection of Kaposi's sarcoma-associated herpesvirus is initiated by the immediate early transcriptional activator protein Rta/open reading frame 50 (ORF50). We examined the transcriptional regulation of the ORF50 core promoter in response to lytic cycle stimulation. We show that the ORF50 promoter is highly responsive to sodium butyrate (NaB) and trichostatin A (TSA), two chemicals known to inhibit histone deacetylases. The NaB and TSA responsive element was mapped to a 70-bp minimal promoter containing an essential GC box that binds Sp1/Sp3 in vitro and in vivo. Micrococcal nuclease mapping studies revealed that a nucleosome is positioned over the transcriptional initiation and the Sp1/3 binding sites. Stimulation with NaB or TSA increased histone acetylation and restriction enzyme accessibility of the ORF50 promoter transcription initiation site. Chromatin immunoprecipitation assay was used to demonstrate that the ORF50 promoter is associated with several different histone deacetylase proteins (including HDAC1, 5, and 7) in latently infected cells. NaB treatment led to the rapid association of Ini1/Snf5, a component of the Swi/Snf family of chromatin remodeling proteins, with the ORF50 promoter. Ectopic expression of the CREB-binding protein (CBP) histone acetyltransferase (HAT) stimulated plasmid-based ORF50 transcription in a HAT-dependent manner, suggesting that CBP recruitment to the ORF50 promoter can be an initiating event for transcription and viral reactivation. Together, these results suggest that remodeling of a stably positioned nucleosome at the transcriptional initiation site of ORF50 is a regulatory step in the transition from latent to lytic infection.
引用
收藏
页码:11425 / 11435
页数:11
相关论文
共 74 条
[31]   Function and selectivity of bromodomains in anchoring chromatin-modifying complexes to promoter nucleosomes [J].
Hassan, AH ;
Prochasson, P ;
Neely, KE ;
Galasinski, SC ;
Chandy, M ;
Carrozza, MJ ;
Workman, JL .
CELL, 2002, 111 (03) :369-379
[32]   The molecular pathology of Kaposi's sarcoma-associated herpesvirus [J].
Jenner, RG ;
Boshoff, C .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2002, 1602 (01) :1-22
[33]  
Katano H, 2001, J HUMAN VIROL, V4, P96
[34]   Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus [J].
Kedes, DH ;
Lagunoff, M ;
Renne, R ;
Ganem, D .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (10) :2606-2610
[35]   The KSHV latency-associated nuclear antigen: A multifunctional protein [J].
Komatsu, T ;
Ballestas, ME ;
Barbera, AJ ;
Kaye, KM .
FRONTIERS IN BIOSCIENCE, 2002, 7 :D726-D730
[36]   The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jκ (CSL), the target of the Notch signaling pathway [J].
Liang, YY ;
Chang, J ;
Lynch, SJ ;
Lukac, DM ;
Ganem, D .
GENES & DEVELOPMENT, 2002, 16 (15) :1977-1989
[37]   Nucleosome sliding via TBP DNA binding in vivo [J].
Lomvardas, S ;
Thanos, D .
CELL, 2001, 106 (06) :685-696
[38]   Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein [J].
Lukac, DM ;
Renne, R ;
Kirshner, JR ;
Ganem, D .
VIROLOGY, 1998, 252 (02) :304-312
[39]   DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters [J].
Lukac, DM ;
Garibyan, L ;
Kirshner, JR ;
Palmeri, D ;
Ganem, D .
JOURNAL OF VIROLOGY, 2001, 75 (15) :6786-6799
[40]   Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant [J].
Martin, DF ;
Kuppermann, BD ;
Wolitz, RA ;
Palestine, AG ;
Li, H ;
Robinson, CA .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (14) :1063-1070